Strategic Investment Advisors / MI
Position in JNJ — Johnson & Johnson
CIK 1760540
FARMINGTON HILLS, MI
Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,148,960
+$6,203 QoQ
Shares Held
4,524
-3.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#2,878
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Investment Advisors / MI holds $15,039,322 across 11 Drug Manufacturers - General names. JNJ ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,165 | $3,564,480 | |
| 2 | LLY |
ELI LILLY & Co
|
2,376 | $2,849,845 | |
| 3 | AMGN |
Amgen Inc
|
7,664 | $2,775,287 | |
| 4 | PFE |
Pfizer Inc
|
48,044 | $1,156,899 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
4,524 | $1,148,960 | |
| 6 | SNY |
Sanofi
|
25,867 | $1,103,486 | |
| 7 | MRK |
Merck & Co., Inc.
|
6,694 | $860,179 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,340 | $674,655 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,148,960 | 4,524 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,142,757 | 4,675 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $767,370 | 3,708 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $665,472 | 3,589 | Shares | Sole | 2025-12-17 | |
| 2025-06-30 | $560,134 | 3,667 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $553,905 | 3,340 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $533,069 | 3,686 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $581,147 | 3,586 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $544,299 | 3,724 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $596,692 | 3,772 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $522,884 | 3,336 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,354,713 | 8,698 | Shares | Sole | 2023-10-25 | |
| 2023-03-31 | $844,750 | 5,450 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $981,997 | 5,559 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $879,530 | 5,384 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $943,465 | 5,315 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $902,809 | 5,094 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $904,618 | 5,288 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $828,818 | 5,132 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $833,913 | 5,062 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $779,840 | 4,745 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $427,286 | 2,715 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $497,854 | 3,344 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $411,061 | 2,923 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $392,996 | 2,997 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||